NASDAQ:SIBN SiBone (SIBN) Stock Price, News & Analysis $19.47 -0.21 (-1.07%) Closing price 10/14/2026 04:00 PM EasternExtended Trading$19.45 -0.02 (-0.10%) As of 10/14/2026 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About SiBone Stock (NASDAQ:SIBN) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get SiBone alerts:Sign Up Key Stats Today's Range$19.42▼$19.8750-Day Range$18.04▼$20.1052-Week Range$11.48▼$21.89Volume407,809 shsAverage Volume590,988 shsMarket Capitalization$863.48 millionP/E RatioN/ADividend YieldN/APrice Target$24.50Consensus RatingModerate Buy Company Overview SI-BONE, Inc. is a medical device company focused on developing and commercializing products for the surgical treatment of disorders affecting the sacroiliac joint, which connects the spine to the pelvis. The company’s technology is intended to support minimally invasive procedures for patients with sacroiliac joint dysfunction and related conditions. Its product portfolio includes the iFuse Implant System, a family of triangular titanium implants designed to stabilize and fuse the sacroiliac joint. SI-BONE also offers products such as iFuse-3D, iFuse-TORQ and the iFuse Bedrock Granite system, which is designed for sacroiliac joint fusion in connection with certain adult lumbopelvic fusion procedures. The company provides associated surgical instruments and procedural technologies for use by spine and orthopedic surgeons. SI-BONE was founded in 2008 and is headquartered in Santa Clara, California. The company markets its products primarily through a direct sales organization and distributors in the United States and select international markets. Its shares began trading publicly on the Nasdaq under the symbol “SIBN” in 2018.AI Generated. May Contain Errors. Read More SiBone Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks69th Percentile Overall ScoreSIBN MarketRank™: 3.440294581795 of 5 starsSiBone scored higher than 69% of companies evaluated by MarketBeat, and ranked 282nd out of 873 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.2 / 5Analyst RatingModerate Buy Consensus RatingSiBone has received a consensus rating of Moderate Buy. The company's average rating score is 2.71, and is based on no strong buy ratings, 6 buy ratings, no hold ratings, and 1 sell rating.Upside PotentialSiBone has a consensus price target of $24.50, representing about 25.8% upside from its current price of $19.47.Amount of Analyst CoverageSiBone has only been the subject of 4 research reports in the past 90 days.Read more about SiBone's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for SiBone are expected to grow in the coming year, from ($0.40) to ($0.33) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of SiBone is -57.26, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of SiBone is -57.26, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioSiBone has a P/B Ratio of 4.76. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about SiBone's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted12.02% of the float of SiBone has been sold short.Short Interest Ratio / Days to CoverSiBone has a short interest ratio ("days to cover") of 8.66.Change versus previous monthShort interest in SiBone has recently decreased by 13.49%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldSiBone does not currently pay a dividend.Dividend GrowthSiBone does not have a long track record of dividend growth. News and Social Media3.0 / 5News Sentiment0.81 News SentimentSiBone has a news sentiment score of 0.81. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.News Coverage This WeekMarketBeat has tracked 9 news articles for SiBone this week, compared to 3 articles on an average week.Search InterestOnly 1 people have searched for SIBN on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.MarketBeat Follows1 people have added SiBone to their MarketBeat watchlist in the last 30 days. Company Ownership1.6 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, SiBone insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $4,368,118.00 in company stock.Percentage Held by Insiders4.00% of the stock of SiBone is held by insiders.Percentage Held by Institutions98.11% of the stock of SiBone is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about SiBone's insider trading history. Receive SIBN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for SiBone and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. SIBN Stock News HeadlinesSiBone (NASDAQ:SIBN) CEO Sells $762,020.30 in Stock2 hours ago | insidertrades.comIs SI-BONE Inc (SIBN) Overvalued After 3.8% Rally? GF Value Says OvervaluedOctober 12 at 10:00 PM | gurufocus.comLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top S&P 500 stock for 12 years running—and today, he's giving away his #1 AI stock pick for 2026, free. This company's sales are up 28% year over year, it holds over 30,000 patents in wireless and video technology, and it just earned an A-rating in his proprietary Stock Grader system that has cost him $9 million to build and maintain.October 15 at 1:00 AM | InvestorPlace (Ad)SiBone (NASDAQ:SIBN) and Nexalin Technology (NASDAQ:NXL) Financial ContrastOctober 12 at 5:29 AM | americanbankingnews.comSiBone (NASDAQ:SIBN) Stock: Insider Anshul Maheshwari Sells 3,318 SharesOctober 8, 2026 | americanbankingnews.comSiBone (NASDAQ:SIBN) Stock: Insider Michael Pisetsky Sells 3,133 SharesOctober 8, 2026 | americanbankingnews.comSiBone (NASDAQ:SIBN) Stock: Insider Anshul Maheshwari Sells 1,731 SharesOctober 7, 2026 | insidertrades.comSiBone (NASDAQ:SIBN) Director Sells $369,400.00 in StockOctober 6, 2026 | insidertrades.comSee More Headlines SIBN Stock Analysis - Frequently Asked Questions How have SIBN shares performed this year? SiBone's stock was trading at $19.72 at the start of the year. Since then, SIBN shares have decreased by 1.3% and is now trading at $19.47. How were SiBone's earnings last quarter? SiBone (NASDAQ:SIBN) posted its quarterly earnings data on Monday, August, 3rd. The company reported ($0.09) earnings per share for the quarter, topping the consensus estimate of ($0.15) by $0.06. The company had revenue of $56.01 million for the quarter, compared to analysts' expectations of $55.34 million. SiBone had a negative trailing twelve-month return on equity of 8.23% and a negative net margin of 6.85%. Read the conference call transcript. Does SiBone have any subsidiaries? The following companies are subsidiaries of SiBone: SI-BONE Deutschland GmbH, SI-BONE S.R.L., and SI-BONE UK LTD. When did SiBone IPO? SiBone (SIBN) raised $84 million in an IPO on Wednesday, October 17th 2018. The company issued 6,000,000 shares at $13.00-$15.00 per share. Morgan Stanley and BofA Merrill Lynch served as the underwriters for the IPO and Canaccord Genuity and JMP Securities were co-managers. How do I buy shares of SiBone? Shares of SIBN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of SiBone own? Based on aggregate information from My MarketBeat watchlists, some other companies that SiBone investors own include NVIDIA (NVDA), Plug Power (PLUG), Eli Lilly and Company (LLY), Bristol Myers Squibb (BMY), Allogene Therapeutics (ALLO), Advanced Micro Devices (AMD) and Belite Bio (BLTE). Company Calendar Last Earnings8/03/2026Today10/14/2026Next Earnings (Estimated)11/09/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (3m+) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 SIBN's financial health is in the Green zone, according to TradeSmith. SIBN has been in this zone for over 3 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNASDAQ:SIBN CIK1459839 Webwww.si-bone.com Phone(408) 207-0700FaxN/AEmployees376Year Founded2008Price Target and Rating Average Price Target for SiBone$24.50 High Price Target$27.00 Low Price Target$20.00 Potential Upside/Downside+25.8%Consensus RatingModerate Buy Rating Score (0-4)2.71 Research Coverage7 Analysts Profitability EPS (Trailing Twelve Months)($0.34) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$18.90 million Net Margins-6.85% Pretax Margin-6.85% Return on Equity-8.23% Return on Assets-6.07% Debt Debt-to-Equity Ratio0.20 Current Ratio9.15 Quick Ratio7.55 Sales & Book Value Annual Sales$213.60 million Price / Sales4.04 Cash FlowN/A Price / Cash FlowN/A Book Value$4.09 per share Price / Book4.76Miscellaneous Outstanding Shares44,349,000Free Float42,575,000Market Cap$863.48 million OptionableOptionable Beta0.66 Social Links 7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free Report This page (NASDAQ:SIBN) was last updated on 10/14/2026 by MarketBeat.com Staff. From Our PartnersReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredBank of America: 'Digital Dollar Inevitable'Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...Decentralized Masters | SponsoredHere’s Why Trump Won’t End The Iran WarTrump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...Banyan Hill Publishing | SponsoredYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...Profits Run | SponsoredThese gold assets are priced for $1,800 gold [it's over $4,000]Gold's major miners are generating record free cash flow, with margins as high as 75 percent even after gold's...Golden Portfolio | SponsoredYour withdrawal order could cost you in taxesIf you have $2M or more saved, the 4% rule points to roughly $92,000 a year - but it's a single-variable answe...SmartAsset | SponsoredElon Musk’s Hushed FCC Filing. Dec 8th.Elon Musk quietly filed a document with the federal government tied to artificial intelligence, one of the lar...Paradigm Press | SponsoredWhy major institutions are piling into this digital asset nowBlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...Awesomely | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SiBone Please log in to your account or sign up in order to add this asset to your watchlist. Share SiBone With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
